Cenra Balance Sheet Health
Financial Health criteria checks 6/6
Cenra has a total shareholder equity of NT$7.4B and total debt of NT$2.7B, which brings its debt-to-equity ratio to 36.9%. Its total assets and total liabilities are NT$12.6B and NT$5.1B respectively. Cenra's EBIT is NT$328.8M making its interest coverage ratio 6.2. It has cash and short-term investments of NT$495.5M.
Key information
36.9%
Debt to equity ratio
NT$2.74b
Debt
| Interest coverage ratio | 6.2x |
| Cash | NT$495.52m |
| Equity | NT$7.44b |
| Total liabilities | NT$5.11b |
| Total assets | NT$12.56b |
Recent financial health updates
We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06Recent updates
China Chemical & Pharmaceutical's (TWSE:1701) Dividend Will Be Reduced To NT$0.50
Jul 12Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching
Apr 25We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On
Mar 17China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 24Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?
Jan 27
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On
Dec 16China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 26Financial Position Analysis
Short Term Liabilities: 1701's short term assets (NT$5.5B) exceed its short term liabilities (NT$3.8B).
Long Term Liabilities: 1701's short term assets (NT$5.5B) exceed its long term liabilities (NT$1.4B).
Debt to Equity History and Analysis
Debt Level: 1701's net debt to equity ratio (30.2%) is considered satisfactory.
Reducing Debt: 1701's debt to equity ratio has reduced from 56.8% to 36.9% over the past 5 years.
Debt Coverage: 1701's debt is well covered by operating cash flow (23.2%).
Interest Coverage: 1701's interest payments on its debt are well covered by EBIT (6.2x coverage).